Inicio>>Signaling Pathways>> Apoptosis>> Other Apoptosis>>Glaucocalyxin A

Glaucocalyxin A

Catalog No.GC38606

La glaucocalyxina A, un diterpeno ent-kauranoide de Rabdosia japonica var., induce la apoptosis en el osteosarcoma al inhibir la translocaciÓn nuclear del dedo de cinco zinc Glis 1 (GLI1) mediante la regulaciÓn de la vÍa de seÑalizaciÓn PI3K/Akt. La glaucocalixina A tiene efecto antitumoral.

Products are for research use only. Not for human use. We do not sell to patients.

Glaucocalyxin A Chemical Structure

Cas No.: 79498-31-0

Tamaño Precio Disponibilidad Cantidad
1mg
114,00 $
Disponible
5mg
342,00 $
Disponible
10mg
582,00 $
Disponible

Tel:(909) 407-4943 Email: sales@glpbio.com

Reseñas de cliente

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

Glaucocalyxin A, an ent-kauranoid diterpene from Rabdosia japonica var., induces apoptosis in osteosarcoma by inhibiting nuclear translocation of Five-zinc finger Glis 1 (GLI1) via regulating PI3K/Akt signaling pathway. Glaucocalyxin A has antitumor effect[1].

Glaucocalyxin A induces apoptosis by mitochondrial apoptotic pathway through several steps including increasing the Bax/Bcl-2 ratio, triggering the intracellular reactive oxygen species (ROS) generation, reducing mitochondrial membrane potential (MMP), and inducing cleavage of caspase-9 and caspase-3[1].

[1]. Zhu J, et al. Glaucocalyxin A exerts anticancer effect on osteosarcoma by inhibiting GLI1 nucleartranslocation via regulating PI3K/Akt pathway. Cell Death Dis. 2018 Jun 13;9(6):708.

Reseñas

Review for Glaucocalyxin A

Average Rating: 5 ★★★★★ (Based on Reviews and 22 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Glaucocalyxin A

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.